ACHIEVE Study Links Hearing Treatment to Slower Rise in Brain-Health Biomarker

A new analysis of the landmark ACHIEVE (Aging and Cognitive Health Evaluation in Elders) clinical trial suggests that treating hearing loss may slow inflammation- and degeneration-related biological changes in the aging brain. The study 00417-7/fulltext), published in the September 2026 edition of EClinicalMedicine , examined blood samples from older adults who had been randomly assigned to receive either a...

Continue reading at Hearing Tracker

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

This adds biomarker-level biological support to the hearing-treatment-protects-brain-health hypothesis, but the analysis is preliminary; no change to hearing aid fitting protocols is warranted yet, though it strengthens the case for counseling patients on cognitive-health benefits of early intervention.

✦ Why It Matters ✦

If replicated, this would provide the first direct biological evidence — beyond cognitive test scores — that hearing treatment slows neurodegeneration-related processes in older adults, potentially reshaping how audiologists frame the stakes of untreated hearing loss.

✦ Key Points ✦

01New sub-analysis of the ACHIEVE RCT links hearing intervention to slower rises in brain inflammation/degeneration biomarkers.
02ACHIEVE is one of the largest and most rigorous RCTs examining hearing loss treatment and brain health in older adults.
03Biomarkers measured are associated with neuroinflammation and neurodegeneration, not just cognitive test performance.
04Results are consistent with prior ACHIEVE findings showing slowed cognitive decline in higher-risk participants.
05Causal direction is still not fully confirmed; biomarker findings require independent replication.

✦ Claims & Evidence ✦

ClaimEvidenceSupport

Treating hearing loss slows the rise of inflammation- and degeneration-related biological markers in the aging brain.

studypartially supported

Biological changes measured are linked to brain inflammation and neurodegeneration.

studysupported

✦ Research metadata ✦

Publication type: research_article
Evidence level: 1b
Population: Older adults with age-related hearing loss enrolled in the ACHIEVE clinical trial
Intervention: Hearing loss treatment (hearing aids and audiological support)
Comparator: Active control (health education intervention)

Primary outcomes

Change in blood-based biomarkers of brain inflammation and neurodegeneration over time

✦ Related stories ✦

PubMed·Journal article·Research (general)·2mo ago

Impaired speech-in-noise perception in individuals with a history of hearing symptoms after noise exposure

Audiologists should consider supplementing standard audiograms with speech-in-noise testing for patients reporting noise-exposure symptoms, as normal thresholds alone may miss clinically meaningful hearing dysfunction consistent with cochlear synaptopathy (hidden hearing loss).

PubMed·Journal article·Research (general)·3mo ago

Effects of Hearing Intervention on Cognitive Function in Patients with Presbycusis: A Systematic Review and Meta-Analysis

This systematic review and meta-analysis provides the strongest available evidence that hearing intervention positively impacts cognitive function in older adults with age-related hearing loss; audiologists should use these findings to counsel patients and reinforce the...

PubMed·Journal article·Research (general)·3mo ago

The Genetic Causes of Auditory Neuropathy: A Systematic Review

Genetic testing for auditory neuropathy is clinically meaningful because the causative gene can influence cochlear implant candidacy and expected outcomes; audiologists should advocate for genetic workup in confirmed auditory neuropathy cases.

PubMed·Journal article·Research (general)·2mo ago

Hearing Loss in Adults With Diabetes and Prediabetes: A Systematic Review and Meta-Analysis

Audiologists should consider routine hearing screening for adult patients with known diabetes or prediabetes, as this meta-analysis provides strong epidemiological evidence linking both conditions to increased prevalence and severity of hearing loss.

PubMed·Clinical trial·Research (general)·4d ago

Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial

are secondary and exploratory — audiologists should not change practice based on these biomarker findings alone, but the study adds biological plausibility to hearing intervention as a potential tool for brain health preservation.

PubMed·Preprint·Research (general)·2mo ago

Older adults show overexaggerated and larger noise-related degradation in their neural tracking of speech

This finding suggests age-related declines in how the brain tracks speech in noise go beyond peripheral hearing loss; audiologists should be cautious attributing all speech-in-noise difficulty in older adults to the audiogram alone, though the preprint has not yet been...

PubMed·Journal article·Research (general)·2mo ago

ATP6V1B1-A Novel Genetic Association Between Pendred Imaging Phenotype and Renal Tubular Acidosis

Audiologists and otolaryngologists encountering patients with the Pendred imaging phenotype (enlarged vestibular aqueduct/cochlear malformation pattern) should consider ATP6V1B1 mutation testing and prompt referral for renal evaluation, as co-existing distal renal tubular...

PubMed·Journal article·Research (general)·3w ago

Normative Ranges for Auditory Brainstem Response Wave I Amplitude: A Potential Diagnostic Indicator of Cochlear Deafferentation

These normative ranges for ABR Wave I amplitude could support clinical identification of cochlear synaptopathy in patients with normal audiograms but auditory complaints; audiologists should consider this as a supplementary diagnostic tool pending further validation in diverse...